AP NEWS

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Bluebird Bio, Inc. Investors (BLUE)

December 17, 2018

LOS ANGELES--(BUSINESS WIRE)--Dec 17, 2018--Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Bluebird Bio, Inc. investors (“Bluebird” or the “Company”) (NASDAQ: BLUE ) concerning the Company and its officers’ possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click  here  to participate.

On December 1, 2018, Bluebird issued a press release informing investors that it had “announced new long-term data from the completed Phase 1/2 Northstar (HGB-204) study of investigational LentiGlobin™ gene therapy in patients with transfusion-dependent β-thalassemia (TDT) and from the ongoing Phase 1/2 HGB-206 study of LentiGlobin in patients with sickle cell disease (SCD) today at the 60th Annual Meeting of the American Society of Hematology (ASH).” Then on December 3, 2018,  Seeking Alpha  published an article asserting that “results were lower than initial data reported a year ago indicating a lower rate of production of anti-sickling hemoglobin.” On this news, shares of Bluebird stock price fell $6.39 per share, or 5.2%, to close at $116.50 on December 3, 2018, thereby injuring investors.

Follow us for updates on Twitter: twitter.com/GPM_LLP.

If you purchased Bluebird securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com:https://www.businesswire.com/news/home/20181217005662/en/

CONTACT: Glancy Prongay and Murray LLP, Los Angeles

Lesley Portnoy, 310-201-9150 or 888-773-9224

www.glancylaw.com

shareholders@glancylaw.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: PROFESSIONAL SERVICES LEGAL

SOURCE: Glancy Prongay & Murray LLP

Copyright Business Wire 2018.

PUB: 12/17/2018 12:46 PM/DISC: 12/17/2018 12:46 PM

http://www.businesswire.com/news/home/20181217005662/en

AP RADIO
Update hourly